{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:12:04Z","timestamp":1789215124426,"version":"build-2803163510"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Austrian Science Funds","award":["FWF SFB F4410 (NS)"],"award-info":[{"award-number":["FWF SFB F4410 (NS)"]}]},{"name":"Austrian Science Funds","award":["P22969-B11 (FF)"],"award-info":[{"award-number":["P22969-B11 (FF)"]}]},{"name":"NIAAA Intramural Research Program"},{"name":"Department of Defense in the Center for Neuroscience and Regenerative Medicine (AH)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.neuropharm.2012.06.001","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T14:16:35Z","timestamp":1340028995000},"page":"414-423","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model"],"prefix":"10.1016","volume":"64","author":[{"given":"Nigel","family":"Whittle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schmuckermair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Gunduz Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hauschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ferraguti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Singewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.06.001_bib1","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1460-9568.2006.04603.x","article-title":"Enhancement of conditioned fear extinction by infusion of the GABA agonist muscimol into the rat prefrontal cortex and amygdala","volume":"23","author":"Akirav","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/070674379804300109","article-title":"Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy","volume":"43","author":"Baetz","year":"1998","journal-title":"Can. J. Psychiatry Revue canadienne de psychiatrie"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib3","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1523\/JNEUROSCI.0079-12.2012","article-title":"HDAC1 regulates fear extinction in mice","volume":"32","author":"Bahari-Javan","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nbt.1759","article-title":"Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes","volume":"29","author":"Bantscheff","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib5","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial","volume":"283","author":"Barlow","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib6","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/npp.2012.44","article-title":"Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy","volume":"37","author":"Bewernick","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1037\/h0026779","article-title":"Crouching as an index of fear","volume":"67","author":"Blanchard","year":"1969","journal-title":"J.\u00a0Comp. Physiol. Psychol."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib8","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/npp.2010.117","article-title":"Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B\/H4 acetylation-dependent transcriptional events in the rat hippocampus","volume":"35","author":"Bousiges","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1101\/lm.801108","article-title":"The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear","volume":"15","author":"Bredy","year":"2008","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1101\/lm.500907","article-title":"Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear","volume":"14","author":"Bredy","year":"2007","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib11","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.2741\/3348","article-title":"Deep brain stimulation for refractory obsessive-compulsive disorder","volume":"14","author":"Burdick","year":"2009","journal-title":"Front. Biosci.: a Journal and Virtual Library"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1601-183X.2009.00519.x","article-title":"Impaired Pavlovian fear extinction is a common phenotype across genetic lineages of the 129 inbred mouse strain","volume":"8","author":"Camp","year":"2009","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2011.340","article-title":"Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes","author":"Camp","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.npp.1300655","article-title":"Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear","volume":"30","author":"Chhatwal","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib15","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nn1718","article-title":"Amygdala BDNF signaling is required for consolidation but not encoding of extinction","volume":"9","author":"Chhatwal","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4088\/JCP.v59n0207b","article-title":"Valproate monotherapy in an SRI-intolerant OCD patient","volume":"59","author":"Cora-Locatelli","year":"1998","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.neuropharm.2011.09.001","article-title":"NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear","volume":"62","author":"Dalton","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2009.06.028","article-title":"Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury","volume":"163","author":"Dash","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib19","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archpsyc.61.10.1005","article-title":"Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia","volume":"61","author":"Davidson","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2006.03.084","article-title":"Effects of D-cycloserine on extinction: translation from preclinical to clinical work","volume":"60","author":"Davis","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/JCP.0b013e318160f83b","article-title":"Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population","volume":"28","author":"Davis","year":"2008","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.31887\/DCNS.2011.13.4\/mdavis","article-title":"NMDA receptors and fear extinction: implications for cognitive behavioral therapy","volume":"13","author":"Davis","year":"2011","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib23","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/sj.mp.4002073","article-title":"mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity","volume":"13","author":"Fendt","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib24","first-page":"361","article-title":"Valproate in combat-related posttraumatic stress disorder","volume":"52","author":"Fesler","year":"1991","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/appi.ajp.162.1.151","article-title":"Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder","volume":"162","author":"Foa","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mcn.2008.06.009","article-title":"Histone deacetylase inhibitors improve learning consolidation in young and in KA-induced-neurodegeneration and SAMP-8-mutant mice","volume":"39","author":"Fontan-Lozano","year":"2008","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib27","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2008"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.biopsych.2009.11.028","article-title":"Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design","volume":"67","author":"Goodman","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib29","article-title":"Pharmacological enhancement of fear reduction: preclinical models","author":"Graham","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib30","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1176\/appi.ajp.2011.11071108","article-title":"Neurocognitive response to deep brain stimulation for obsessive-compulsive disorder: a case report","volume":"168","author":"Grant","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/mp.2008.55","article-title":"Deep brain stimulation of the ventral internal capsule\/ventral striatum for obsessive-compulsive disorder: worldwide experience","volume":"15","author":"Greenberg","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/15622975.2011.583940","article-title":"Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation","volume":"12","author":"Grubert","year":"2011","journal-title":"World J. Biol. Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib34","first-page":"89","article-title":"A\u00a0preliminary controlled trial of divalproex in posttraumatic stress disorder","volume":"21","author":"Hamner","year":"2009","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1037\/0735-7044.113.5.925","article-title":"An infusion of bupivacaine into the nucleus accumbens disrupts the acquisition but not the expression of contextual fear conditioning","volume":"113","author":"Haralambous","year":"1999","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s002130050745","article-title":"Evidence that GABA transmission mediates context-specific extinction of learned fear","volume":"140","author":"Harris","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib37","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1523\/JNEUROSCI.4904-07.2008","article-title":"Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain","volume":"28","author":"Hefner","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1460-9568.2010.07101.x","article-title":"Neuronal circuits of fear extinction","volume":"31","author":"Herry","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib39","doi-asserted-by":"crossref","first-page":"10947","DOI":"10.1523\/JNEUROSCI.2603-07.2007","article-title":"A\u00a0pathway-specific function for different AMPA receptor subunits in amygdala long-term potentiation and fear conditioning","volume":"27","author":"Humeau","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.npp.1300530","article-title":"The nucleus accumbens is not critically involved in mediating the effects of a safety signal on behavior","volume":"30","author":"Josselyn","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib41","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.1214592","article-title":"Fear erasure in mice requires synergy between antidepressant drugs and extinction training","volume":"334","author":"Karpova","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib42","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders","volume":"7","author":"Kazantsev","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib43","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0006-3223(93)90010-B","article-title":"Valproate treatment of panic disorder and lactate-induced panic attacks","volume":"33","author":"Keck","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib45","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/npp.2009.197","article-title":"Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease","volume":"35","author":"Kilgore","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib46","first-page":"169","article-title":"Valproic acid for the treatment of social anxiety disorder","volume":"18","author":"Kinrys","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0361-9230(96)00268-7","article-title":"The effects of anticonvulsant drugs on NMDA-EPSP, AMPA-EPSP, and GABA-IPSP in the rat hippocampus","volume":"42","author":"Ko","year":"1997","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib48","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"Kramer","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00213-011-2353-x","article-title":"Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial","volume":"218","author":"Kuriyama","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib50","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1037\/0735-7044.121.5.1125","article-title":"Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction","volume":"121","author":"Lattal","year":"2007","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1037\/0735-7044.117.2.341","article-title":"Effects of D-cycloserine on extinction of conditioned freezing","volume":"117","author":"Ledgerwood","year":"2003","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nn.2999","article-title":"Bidirectional modulation of fear extinction by mediodorsal thalamic firing in mice","volume":"15","author":"Lee","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib53","doi-asserted-by":"crossref","first-page":"40545","DOI":"10.1074\/jbc.M402229200","article-title":"Regulation of histone acetylation during memory formation in the hippocampus","volume":"279","author":"Levenson","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0166-4328(02)00287-5","article-title":"Nucleus accumbens dopamine and learned fear revisited: a review and some new findings","volume":"137","author":"Levita","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib55","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pbb.2006.08.015","article-title":"The effects of chronic valproate and diazepam in a mouse model of posttraumatic stress disorder","volume":"85","author":"Li","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib56","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.neuropharm.2007.11.005","article-title":"The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats","volume":"54","author":"Li","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib57","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.biopsych.2009.04.003","article-title":"Block of gamma-aminobutyric acid-a receptor insertion in the amygdala impairs extinction of conditioned fear","volume":"66","author":"Lin","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/01.neu.0000279719.75403.f7","article-title":"Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: the search for a valid target","volume":"61","author":"Lipsman","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib59","doi-asserted-by":"crossref","first-page":"17907","DOI":"10.1074\/jbc.M109.080838","article-title":"The metabotropic glutamate receptor mGlu7 activates phospholipase C, translocates munc-13-1 protein, and potentiates glutamate release at cerebrocortical nerve terminals","volume":"285","author":"Martin","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib60","doi-asserted-by":"crossref","first-page":"12601","DOI":"10.1523\/JNEUROSCI.3750-07.2007","article-title":"High-frequency deep brain stimulation of the nucleus accumbens region suppresses neuronal activity and selectively modulates afferent drive in rat orbitofrontal cortex in\u00a0vivo","volume":"27","author":"McCracken","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib61","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1523\/JNEUROSCI.0131-09.2009","article-title":"Nucleus accumbens deep brain stimulation produces region-specific alterations in local field potential oscillations and evoked responses in\u00a0vivo","volume":"29","author":"McCracken","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.287.5451.248","article-title":"Memory\u2013a century of consolidation","volume":"287","author":"McGaugh","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004691-200401000-00006","article-title":"How does deep brain stimulation work? Present understanding and future questions","volume":"21","author":"McIntyre","year":"2004","journal-title":"J.\u00a0Clin. Neurophysiol.: Official Publication of the American Electroencephalographic Society"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib64","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1523\/JNEUROSCI.5052-10.2011","article-title":"HDAC3 is a critical negative regulator of long-term memory formation","volume":"31","author":"McQuown","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib65","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.biopsych.2009.06.026","article-title":"Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder","volume":"66","author":"Milad","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib66","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1074\/jbc.M109044200","article-title":"The inhibition of glutamate release by metabotropic glutamate receptor 7 affects both [Ca2+]c and cAMP: evidence for a strong reduction of Ca2+ entry in single nerve terminals","volume":"277","author":"Millan","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-2999(88)90461-X","article-title":"'GABA shift' in\u00a0vivo: enhancement of benzodiazepine binding in\u00a0vivo by modulation of endogenous GABA","volume":"148","author":"Miller","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib68","first-page":"205","article-title":"Effects of seizures and antiepileptic drugs on benzodiazepine receptors in rat brain","volume":"4","author":"Mimaki","year":"1984","journal-title":"Pediatr. Pharmacol. (New York)"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib69","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1073\/pnas.0508063102","article-title":"A\u00a0selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in\u00a0vivo","volume":"102","author":"Mitsukawa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib70","doi-asserted-by":"crossref","first-page":"e19958","DOI":"10.1371\/journal.pone.0019958","article-title":"Epigenetic alterations are critical for fear memory consolidation and synaptic plasticity in the lateral amygdala","volume":"6","author":"Monsey","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.mp.4001939","article-title":"Mechanisms of fear extinction","volume":"12","author":"Myers","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib72","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/npp.2010.88","article-title":"Glutamate receptors in extinction and extinction-based therapies for psychiatric illness","volume":"36","author":"Myers","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib73","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A\u00a0meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy","volume":"63","author":"Norberg","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib74","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s002210050304","article-title":"Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. I. Evidence from chronaxie measurements","volume":"118","author":"Nowak","year":"1998","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib75","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s002210050305","article-title":"Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. II. Evidence from selective inactivation of cell bodies and axon initial segments","volume":"118","author":"Nowak","year":"1998","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib76","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S1092852900009901","article-title":"Overview of diagnosis and drug treatments of anxiety disorders","volume":"10","author":"Nutt","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib109","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2010.02.059","article-title":"Metabotropic glutamate receptor 7: at the interface of cognition and emotion","volume":"639","author":"O'Connor","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(95)12207-9","article-title":"Presynaptic localization of a metabotropic glutamate receptor, mGluR7, in the primary afferent neurons: an immunohistochemical study in the rat","volume":"202","author":"Ohishi","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib78","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.2006.095315","article-title":"Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming","volume":"78","author":"Okun","year":"2007","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1468-1331.2011.03590.x","article-title":"The economic cost of brain disorders in Europe","volume":"19","author":"Olesen","year":"2012","journal-title":"Eur. J. Neurol.: the Official Journal of the European Federation of Neurological Societies"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2011.12.014","article-title":"Neural and cellular mechanisms of fear and extinction memory formation","author":"Orsini","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib81","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.jcp.0000106234.36344.a4","article-title":"Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study","volume":"24","author":"Otte","year":"2004","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib82","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1152\/physrev.00037.2009","article-title":"Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear","volume":"90","author":"Pape","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib83","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.1186088","article-title":"Altered histone acetylation is associated with age-dependent memory impairment in mice","volume":"328","author":"Peleg","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib84","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/070674379003500309","article-title":"Valproic acid and panic disorder","volume":"35","author":"Primeau","year":"1990","journal-title":"Can. journal Psychiatry Revue Canadienne De Psychiatrie"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib85","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.npp.1301555","article-title":"Neural mechanisms of extinction learning and retrieval","volume":"33","author":"Quirk","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib86","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear","volume":"61","author":"Ressler","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib87","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1101\/lm.78204","article-title":"Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications","volume":"11","author":"Richardson","year":"2004","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib88","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1097\/00001756-199707280-00013","article-title":"Nucleus accumbens lesions impair context, but not cue, conditioning in rats","volume":"8","author":"Riedel","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib89","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1200782109","article-title":"Deep brain stimulation of the ventral striatum enhances extinction of conditioned fear","author":"Rodriguez-Romaguera","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib90","first-page":"12","article-title":"Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system","volume":"299","author":"Schoepp","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib91","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jnnp.2005.069906","article-title":"Panic and fear induced by deep brain stimulation","volume":"77","author":"Shapira","year":"2006","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib92","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/WNR.0b013e328307f295","article-title":"Amygdaloid metabotropic glutamate receptor subtype 7 is involved in the acquisition of conditioned fear","volume":"19","author":"Siegl","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib93","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1073\/pnas.0510341103","article-title":"The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases","volume":"103","author":"Simonini","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib94","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1126\/science.1181886","article-title":"A\u00a0genetic variant BDNF polymorphism alters extinction learning in both mouse and human","volume":"327","author":"Soliman","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib95","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/sj.npp.1301316","article-title":"Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala","volume":"32","author":"Sotres-Bayon","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2012.06.001_bib96","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biopsych.2011.12.012","article-title":"Increasing histone acetylation in the hippocampus-infralimbic network enhances fear extinction","volume":"72","author":"Stafford","year":"2012","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib97","article-title":"Pharmacological treatment of PTSD \u2013 established and new approaches","author":"Steckler","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib98","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1124\/jpet.110.177378","article-title":"The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?","volume":"338","author":"Sukoff Rizzo","year":"2011","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib99","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.conb.2004.04.001","article-title":"Mitogen-activated protein kinases in synaptic plasticity and memory","volume":"14","author":"Sweatt","year":"2004","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib100","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2004.11.046","article-title":"Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice","volume":"57","author":"Tremolizzo","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib101","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tins.2011.10.003","article-title":"Fear conditioning and extinction: emotional states encoded by distinct signaling pathways","volume":"35","author":"Tronson","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib102","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jneumeth.2011.04.034","article-title":"Unilateral deep brain stimulation in the nucleus accumbens core does not affect local monoamine release","volume":"202","author":"van Dijk","year":"2011","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib103","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0091-3057(01)00698-0","article-title":"The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction","volume":"71","author":"Walker","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib104","doi-asserted-by":"crossref","first-page":"13586","DOI":"10.1523\/JNEUROSCI.0849-10.2010","article-title":"Rescue of impaired fear extinction and normalization of cortico-amygdala circuit dysfunction in a genetic mouse model by dietary zinc restriction","volume":"30","author":"Whittle","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.001_bib105","first-page":"134","article-title":"Panic disorder: treatment with valproate","volume":"55","author":"Woodman","year":"1994","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib106","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1038\/npp.2009.86","article-title":"Pharmacological discrimination of extinction and reconsolidation of contextual fear memory by a potentiator of AMPA receptors","volume":"34","author":"Yamada","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2007.09.006","article-title":"Response variation following trauma: a translational neuroscience approach to understanding PTSD","volume":"56","author":"Yehuda","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.06.001_bib108","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1523\/JNEUROSCI.3842-06.2007","article-title":"Facilitation of extinction learning for contextual fear memory by PEPA: a potentiator of AMPA receptors","volume":"27","author":"Zushida","year":"2007","journal-title":"J.\u00a0Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T18:09:47Z","timestamp":1642529387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812002596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":109,"alternative-id":["S0028390812002596"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.06.001","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}